Abstract
An 11 year old male presented with headache, vomiting and weakness of right side of body. One day after admission he developed right focal seizures. He had 5 previous episodes of stroke, the first at 11 months age. His milestones were normal upto the first episode but subsequent mile stones were delayed. His serum and CSF lactic acids were raised. Muscle biopsy showed ragged red fibres on modified Gomori-trichrome staining. His EEG, CT scan and MRI were normal this time. The child improved spontaneously after 7 days. His recovery time progressively became shorter with each episode of stroke. Maximum time for recovery was noted during first episode and least in current episode. This is the first report of Melas syndrome in Indian literature.
References
Pavlakis SG, Phillips PC, Dimauros S, Devivo DC, Rowland LP Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke like eposide: A distinctive clinical syndrome.Ann Neurol 1984; 16 : 481–88.
Driscoll PF, Larsen PD, Gruber AB. MELAS syndrome involving a mother and two children.Arch Neurol 1987; 44: 971–73.
Kishnani PS, Van Hove JLK, Shoffner JS, Kaufman A, Bossen EH, Kahler SG. Acute pancreatitis in an infant with lactic acidosis and a mutation at nucleotide 3243 in the mitochondrial DNA tRNALeu (uur) Gene.Eur J Pediatr 1996; 155: 898–903.
Ciafaloni E, Ricci E, Shanske Set al. MELAS: Clincal features, biochemistry and molecular genetics.Ann Neurol 1992; 31: 391–98.
Fujii T, Okuno T, Ito Net al. MELAS of infantile onset : mitochondrial angiopathy or cytopathy?J Neurol Scie. 1991 :37–41.
Koo B, Becker LE, Chuang Set al. Mitochondrial encephalomyopathy, lactic acidosis, stroke-like episode (MELAS): Clinical radiological, pathological and genetics observations.Ann Neurol 1993; 34 : 25–32.
Fukuhara N, Tokiguchi S, Shriakawa K, Tsubaki T. Myoclonus epilepsy associated with ragged red fibre: disease entity or a syndrome? Light and electron microscopic studies of two cases and review of literature.J Neurol Sci 1980; 47: 117–33.
Rowland LP, Hays AP, Dimauro Set al. Diverse clinical disorders associated with morphological abnormalities of mitochondria. In: Cerri C, Scarlato G (eds).Mitoehondrial Pathology in Muscle Diseases. Padua, Piccin editore. 1983; pp. 141–158 (Quoted from reference No. 1).
Liou C-W, Huang C-C, Chee EC-Yet al. Melas syndrome: Correlation between clinical features and molecular genetic analysis.Acta Neurol Stand 1994; 90 : 354–59.
Wong LTC. Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke like episode (MELAS) triggered by valproate therapy.Eur J Pediatr. 1997; 156: 562–64.
Clark JM, Marks MR Actalsteinsson Eet al. Clinical and pathological correlation with MRI, Xenon/CT and MRI spectroscopy.Neurology, 1996; 46(1), 223–7.
Tulinius MH, Hayne I. EEG findings in children and adolescent with mitochondrial encephalomyopathies: A study of 25 cases.Brain Dev. 1991; 13: 167–173.
Ikejiri Y, Mori E, Ishii K, Nishimoto K, Yashuda M, Sasaki M. Indebenone improves cerebral mitochondrial oxidative metabolism in a patient with MELAS.Neurology 1996; 47: 583–85.
Rodriguez G, Nobili F, Tanganelli P, Regesta G, Ottonello G. Cerebral hyperperfusion antidates by years stroke like episodes in MELAS syndrome.Stroke 1996; 27(2): 341–2.
Gikhrist JM, Sikirica M, Stopa E, Shanske S. Adult onset MELAS. Evidence for involvement of neurones as well as cerebral vasculature in stroke like episodes.Life Sci. 1996; 58 (8): 691–9.
Kobayashi Y, Morishita H, Sujiyama Net al. Two cases of NADH-CoQ reductase deficiency: relationship to MELAS syndrome.J. Pediatr. 1987, 110: 223–27 (Quoted from reference 13).
Hsieh F, Dworkin L. Acute renal failure and MELAS syndrome, a mitochondrial encephalomyopathy.J Am Soc Nephrol 1996; (5) : 647–52.
Suzuki T, Fuzinq T, Sugiyam M, Ishida M. A case of mitochondrial encephalomyopathy.Nippon finzo Gakkaishi 1996; (2), 109–14.
Hagenfeldt L, Von Doblein U, Solders G. Kaijser L. Creatinine treatment in MELAS.Muscle and Nerve 1994; 17(10), 1236–37.
Barak Y, Arnon S, Wolach Bet al. MELAS syndrome: Peripheral neuropathy and cytochrome C-oxidase deficiency: A case report and review of the literature.Isr J Med Sci 1995; 31 : 224–29.
Kovalenko SA, Tanaka M, Yoneda M, Lakoulev AF, Ozawat T. Accumulation of somatic nucleotide substitutions in mitochondrial DNA associated with the 3243 A-to-G tRNA(leu) (UUR) mutation in encephalomyopathy and cardiomyopathy.Biochem Biophys Res Commun 1996, 15; 222(2): 201–7.
Ihara Y, Namba R, Kuroda Set al. Mitochondrial encephalomyopathy (MELAS): Pathological study and successful therapy with COQ10 and idebenone.J Neurol Sci 1989; 90 : 263–71.
Majamaa K, Rusanen H, Remes AM, Pythinen J, Hassinen IE. Increase of blood NAD and attenuation of lactic acidemia during nicotinamide treatment of a patient with MELAS syndrome.Life Sci. 1996; 56 (8): 691–9.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Singh, S.K., Sarin, D., Puliyel, J.M. et al. Melas syndrome. Indian J Pediatr 66, 621–625 (1999). https://doi.org/10.1007/BF02727181
Issue Date:
DOI: https://doi.org/10.1007/BF02727181